solian 100
sanofi-aventis new zealand limited - amisulpride 100mg; ; ; amisulpride 100mg - tablet - 100 mg - active: amisulpride 100mg excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 100mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride 100mg tablets
accord-uk ltd - amisulpride - oral tablet - 100mg
amisulpride sandoz pharma amisulpride 100 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; hypromellose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz pharma amisulpride 200 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 200 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz pharma amisulpride 400 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 400 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate type a; hypromellose; microcrystalline cellulose; magnesium stearate; lactose monohydrate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz 400 amisulpride 400 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride sandoz 200 amisulpride 200 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride sandoz 100 amisulpride 100 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride 400 winthrop amisulpride 400 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; peg-40 stearate; lactose monohydrate; titanium dioxide; hypromellose; microcrystalline cellulose - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride 100mg tablets
dowelhurst ltd - amisulpride - oral tablet - 100mg